Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
56 hedge funds and large institutions have $124M invested in Sorrento Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 3 closing their positions.
600% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 3
47% more funds holding
Funds holding: 38 → 56 (+18)
35% more capital invested
Capital invested by funds: $91.5M → $124M (+$32.1M)
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
34% less call options, than puts
Call options by funds: $1.41M | Put options by funds: $2.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$15.1M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.75M |
| 3 |
Millennium Management
New York
|
+$5.13M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.8M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$12.8M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
-$2.77M |
| 3 |
SCM
Sio Capital Management
New York
|
-$1.86M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.12M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$825K |
SRNE Hedge Fund Activity: Q1 2015 in Review
56 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q1 2015, worth a combined $124M — up 35% from $91.5M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SRNE positions and 3 closed out — a net gain of 18 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $15.1M. The largest seller was JP Morgan Chase, cutting an estimated $12.8M.
- 56 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q1 2015, up from 38 in Q4 2014.
- Funds reported $124M of Sorrento Therapeutics, Inc. stock for Q1 2015, up 35% quarter-over-quarter.
- 21 funds opened new Sorrento Therapeutics, Inc. positions in Q1 2015 and 3 closed out, a net change of +18 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q1 2015 was Avoro Capital Advisors, an estimated $15.1M added.
- The largest Sorrento Therapeutics, Inc. seller in Q1 2015 was JP Morgan Chase, an estimated $12.8M sold.
Based on aggregated 13F filings for Q1 2015.